跳至主要内容
临床试验/NCT02191202
NCT02191202已完成不适用

Observational Study of the Impact on Quality-of-life of a Switch From a Virologically Effective Regimen to a Regimen Containing a Non-Nucleoside Reverse Transcriptase Inhibitor (QUALVI) Nevirapine (Viramune®) Clinical Phase IV

Boehringer Ingelheim0 个研究点目标入组 283 人开始时间: 2004年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
283
主要终点
Changes in World Health Organization Quality of Life - HIV (WHOQOL-HIV) score

研究概览

简要总结

Observational study to evaluate therapeutic switch to a NNRTI-based regimen on quality of life of HIV-positive patients

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • NNRTI-naive patients with positive HIV serology, treated with at least triple combination therapy, with a viral load < 500 copies/ml, in whom a new treatment comprising an NNRTI is initiated for a reason other than inefficacy of treatment will be included
  • Patients must read and write French

排除标准

  • Patients in whom a new treatment is initiated because of treatment failure
  • new treatment does not comprise an NNRTI

研究组 & 干预措施

Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)

干预措施: Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI) (Drug)

结局指标

主要结局

Changes in World Health Organization Quality of Life - HIV (WHOQOL-HIV) score

时间窗: Baseline, month 1, 6 and 12

次要结局

  • Comparison of Short version of the Medical Outcomes Study Short-Form General Health Survey-36 (SF12) scores of the study population compared to the general population(Baseline, 12 months)
  • Changes in liver function tests(Baseline and month 3, 6, 9, 12)
  • Changes in total cholesterol(Baseline, month 6 and 12)
  • Changes in triglycerides(Baseline, month 6 and 12)
  • Changes in fasting blood glucose(Baseline, month 6 and 12)
  • Changes in haemoglobin(Baseline, month 6 and 12)
  • Changes from baseline in plasma urea(Baseline, month 12)
  • Changes from baseline in creatinine(Baseline, month 12)
  • Changes in symptom scale score(Baseline, month 1, 6 and 12)
  • Changes in Hospital Anxiety and Depression scale (HADS)(Baseline, month 1, 6 and 12)
  • Changes in cluster of differentiation 4 (CD4) cell count(Baseline and month 3, 6, 9, 12)
  • Changes in viral load(Baseline and month 3, 6, 9, 12)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验